X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA CADILA HEALTHCARE NATCO PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x 32.5 35.1 92.6% View Chart
P/BV x 16.6 9.0 183.1% View Chart
Dividend Yield % 0.7 0.7 102.1%  

Financials

 NATCO PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
CADILA HEALTHCARE
Mar-16
NATCO PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs877454 193.0%   
Low Rs424305 139.1%   
Sales per share (Unadj.) Rs223.496.1 232.5%  
Earnings per share (Unadj.) Rs31.114.9 208.9%  
Cash flow per share (Unadj.) Rs40.317.8 225.9%  
Dividends per share (Unadj.) Rs5.003.20 156.3%  
Dividend yield (eoy) %0.80.8 91.2%  
Book value per share (Unadj.) Rs219.552.3 419.9%  
Shares outstanding (eoy) m33.071,023.74 3.2%   
Bonus/Rights/Conversions PAFV5:1-  
Price / Sales ratio x2.93.9 73.7%   
Avg P/E ratio x20.925.5 82.0%  
P/CF ratio (eoy) x16.121.3 75.8%  
Price / Book Value ratio x3.07.3 40.8%  
Dividend payout %16.121.5 74.8%   
Avg Mkt Cap Rs m21,504388,458 5.5%   
No. of employees `000NA15.4 0.0%   
Total wages/salary Rs m1,12813,317 8.5%   
Avg. sales/employee Rs ThNM6,371.1-  
Avg. wages/employee Rs ThNM862.4-  
Avg. net profit/employee Rs ThNM986.1-  
INCOME DATA
Net Sales Rs m7,38998,376 7.5%  
Other income Rs m167941 17.8%   
Total revenues Rs m7,55699,317 7.6%   
Gross profit Rs m1,79323,829 7.5%  
Depreciation Rs m3043,022 10.1%   
Interest Rs m366486 75.3%   
Profit before tax Rs m1,29021,262 6.1%   
Minority Interest Rs m46-300 -15.4%   
Prior Period Items Rs m05 0.0%   
Extraordinary Inc (Exp) Rs m0-25 0.0%   
Tax Rs m3095,716 5.4%   
Profit after tax Rs m1,02715,226 6.7%  
Gross profit margin %24.324.2 100.2%  
Effective tax rate %23.926.9 89.0%   
Net profit margin %13.915.5 89.8%  
BALANCE SHEET DATA
Current assets Rs m3,68144,376 8.3%   
Current liabilities Rs m3,12334,071 9.2%   
Net working cap to sales %7.610.5 72.2%  
Current ratio x1.21.3 90.5%  
Inventory Days Days8954 166.2%  
Debtors Days Days5962 94.1%  
Net fixed assets Rs m7,68547,896 16.0%   
Share capital Rs m3311,024 32.3%   
"Free" reserves Rs m6,67048,746 13.7%   
Net worth Rs m7,25953,519 13.6%   
Long term debt Rs m9558,964 10.7%   
Total assets Rs m11,957100,163 11.9%  
Interest coverage x4.544.7 10.1%   
Debt to equity ratio x0.10.2 78.5%  
Sales to assets ratio x0.61.0 62.9%   
Return on assets %11.715.7 74.3%  
Return on equity %14.228.4 49.8%  
Return on capital %20.734.3 60.4%  
Exports to sales %39.445.3 86.9%   
Imports to sales %5.75.9 96.1%   
Exports (fob) Rs m2,90844,537 6.5%   
Imports (cif) Rs m4215,838 7.2%   
Fx inflow Rs m3,44544,881 7.7%   
Fx outflow Rs m7039,069 7.7%   
Net fx Rs m2,74335,812 7.7%   
CASH FLOW
From Operations Rs m1,44019,938 7.2%  
From Investments Rs m-1,089-9,039 12.1%  
From Financial Activity Rs m-353-9,527 3.7%  
Net Cashflow Rs m-11,372 -0.1%  

Share Holding

Indian Promoters % 52.0 74.8 69.6%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 8.3 94.5%  
FIIs % 16.6 5.9 281.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 11.0 236.4%  
Shareholders   25,395 44,069 57.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   UNICHEM LAB  VENUS REMEDIES  STERLING BIOTECH  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare NATCO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 21, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - TTK HEALTHCARE COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS